Captopril and norepinephrine-induced hypertrophy and haemodynamics in rats

Journal of Cardiovascular Pharmacology

Volumn 27, Issue 5, 1996, Pages 667-672

  Laycock, S K ^a   Kane, K A ^a   McMurray, J ^b   Parratt, J R ^a  

^a UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^b WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

Chronic captopril; Chronic norepinephrine; Haemodynamics; Hypertrophy; Rats

Indexed keywords

ASCORBIC ACID; CALCIUM CHLORIDE; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; NORADRENALIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOSE RESPONSE; HEART LEFT VENTRICLE DP-DT; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE CONTRACTILITY; HEART RATE; HEMODYNAMICS; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; SYSTOLIC BLOOD PRESSURE;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; CALCIUM CHLORIDE; CAPTOPRIL; CARDIOMEGALY; HEMODYNAMIC PROCESSES; MALE; NOREPINEPHRINE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, BETA;

EID: 0029913672     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199605000-00008     Document Type: Article

References (23)

1. Kleber FX, Niemoller L, Doering W. Impact of converting enzyme inhibition on progression of chronic heart failure: results of the Munich Mild Heart Trial. Br Heart J 1992;67:289-96.
2. Pfeffer JM, Pfeffer MA, Braunwald E. Haemodynamic benefits and prolonged survival with long term captopril therapy in rats with myocardial infarction and heart failure. Circulation 1987;75: 1149.
3. Lai FM, Tanikella T, Herzlinger H, Thiabauld L, Cevoni P. Effects of continuous angiotensin 1 converting enzyme blockade on blood pressure, sympathetic activity and renin-angiotensin system on stroke-prone spontaneously hypertensive rats. Life Sci 1981;28: 1309-19.
4. van Wijngaarden J, Monnink SHJ, Bartels H, et al. Captopril modifies the response of infarcted rat hearts to isoprenaline stimulation. J Cardiovasc Pharmacol 1992;19:741-7.
5. Atkinson J, Sonnay M, Sautel M, Fouda A-K. Chronic treatment of the spontaneously hypertensive rat with captopril attenuates responses to noradrenaline in vivo but not in vitro. Naunyn Schmiedebergs Arch Pharmacol 1987;335:624-8.
6. Maisel AS, Phillips C, Michel MC, Ziegler MG, Carter SM. Regulation of cardiac β adrenergic receptors by captopril. Circulation 1989;80:669-75.
7. Laycock SK, McMurray J, Kane KA, Parratt JR. The effects of chronic noradrenaline administration on cardiac function in rats. J Cardiovasc Pharmacol 1995;26:584-7.
8. Newman WH, Bush ML. Evaluation of drug-induced alterations in myocardial contractility. In: Wilkerson PD, ed. Cardiac pharmacology, London: Academic Press, 1981:53-73.
9. Brown L, Sernia C, Newling R, Fletcher P. Cardiac responses after norepinephrine-induced ventricular hypertrophy in rats. J Cardiovasc Pharmacol 1992;20:316-23.
10. Johnson MD, Grignolo A, Kuhn Cm, Schanberg SM. Hypertension and cardiovascular hypertrophy during chronic catecholamine infusion in rats. Life Sci 1983;33:169-80.
11. Krumholz HM, Larson M, Levy D. Sex differences in cardiac adaptation to isolated systolic hypertension. Am J Cardiol 1993; 72:310-3.
12. Muller R, Weller SP, Krone W. Plasma catecholamines and adrenoceptors in young hypertensive patients. J Hum Hypertens 1994; 8:351-5.
13. Litwin SE, Litwin CM, Raya TE, Warner AL, Goldman S. Contractility and stiffness of no-infarcted myocardium after coronary artery ligation in rats. Circulation 1991;83:1028-37.
14. Michel JB, Lattion AL, Salzmann JI, et al. Hormonal and cardiac effects of converting enzyme inhibition in rat myocardial infarction. Circ Res 1988;62:641-50.
15. Michel JB, Heudes D, Michel O, et al. Effect of chronic ANG I-converting enzyme inhibition on aging processes. II. Large arteries. Am J Physiol 1994;267:R124-35.
16. Meszaros J, Levai G. Catecholamine-induced cardiac hypertrophy uncouples β-adrenoceptors from slow calcium channels. Eur J Pharmacol 1992;210:333-8.
17. Antonaccio MJ, Kerwin L. Pre- and postjunctional inhibition of vascular sympathetic function by captopril in SHR. Hypertension 1981;3:154-62.
18. de Jong A, Davideskdo D, Mathy M-J, et al. Effect of pithing on the postjunctional sympatho-inhibitory action of captopril in cats. Naunyn Schmiedebergs Arch Pharmacol 1984;328:30-2.
19. Bristow MR, Ginsburg R, Monobe W, et al. Decreased catecholamine sensitivity and β-adrenergic receptor density in failing human hearts. N Engl J Med 1982;307:205-11.
20. McKenna WJ, England D, Doi YL, Deanfield JE, Oakey C, Goodwin JF. Arrhythmias in hypertrophic cardiomyopathy. I. Influence on prognosis. Br Heart J 1981;46:168-72.
21. McLenachan JM, Dargie HJ. Left ventricular hypertrophy as a factor in arrhythmias and sudden death. Am J Hypertens 1989;2: 128-31.
22. Walrus KM, Fondacaro JD, Jacobsen ED. Hemodynamic and metabolic changes during stimulation of ileal motility. Dig Dis Sci 1989;26:1096-2077.
23. Edwards IR, Coulter DM, Mackintosh D. Intestinal effects of captopril. Br Med J 1992;304:359-60.